CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

4.180 -0.02 (-0.48%)

Data as of Jun 17, 2019

Prev. Close 4.2
Price Open 4.275
Volume 391,459
Day's Range 4.17 - 4.35
52 Wk Range -
50 Day Moving Avg.
PE Ratio 0
Shares Outstanding
Market Cap

Trade CVSI stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
5/16/19		Initiates Coverage On	Buy	9.0

The Week In Cannabis: Colorado Hits $1B In Sales, Harborside In Canada, Kroger Embraces CBD, And More Javier HasseSun, 16 Jun 2019 09:11:45 -0400
CV Sciences Announces Supplier Deal With Kroger, Expands Topical Offerings Alex OleinicWed, 12 Jun 2019 14:25:45 -0400
The Week In Cannabis: Canada Funds Research, EU Country Allows Sale Of CBD, NFL Moves Forward Javier HasseSun, 26 May 2019 15:57:32 -0400
Roth Capital Initiates Coverage On CV SCIENCES INC by CV Sciences, Inc. with Buy Rating, Announces $9 Price Target Vick MeyerThu, 16 May 2019 07:40:35 -0400
These Were The Securities With The Biggest Dollar Volume Increases On OTC Markets In April Spencer IsraelTue, 14 May 2019 12:21:12 -0400
Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies ETF ProfessorTue, 16 Apr 2019 12:23:38 -0400
Cannabis Securities Trading on The OTC Markets Saw Dramatic Volume Increases In March Spencer IsraelWed, 10 Apr 2019 13:43:45 -0400
Shares of several Cannabis companies are trading lower after Canadian banks said they will 'steer clear' of the sector until new laws are passed, restricting the cannabis industry's access to banking services. Benzinga NewsdeskMon, 08 Apr 2019 12:28:38 -0400
Hearing Northland Says Walmart, CV Sciences Confirmed 3 Different Sources Suggest CV's CBD Gold Balm Oil, Products Are On Shelves At CVS Stores As Of Fri. Benzinga NewsdeskFri, 22 Mar 2019 10:42:06 -0400
CV Sciences Skewing Successfully Thanks To CBD Sales New Frontier DataThu, 21 Mar 2019 10:40:35 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-Loss Applications Globe Newswire1 hour ago
Groundbreaking Research Proves Efficacy of PlusCBD™ Oil in Sleep, Wellness and Weight-Loss Applications Globe Newswire6 hours ago
Why Cannabis Cultivation Smart Farming Techniques can all Benefit Farm Operations PRNewswire4 days ago
CV Sciences, Inc. to Present at the Oppenheimer 19th Annual Consumer Conference Globe Newswire4 days ago
CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Offering of Topical Products Globe Newswire5 days ago
CV Sciences Comments on FDA CBD Hearing Globe NewswireJun 06, 2019
Upcoming CBD Shortage is an Opportunity for Cost-efficient Producers to Expand PRNewswireMay 30, 2019
CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passing of AB 228 Globe NewswireMay 22, 2019
CBD Market Growth Larger Than Expected Multi-billion Dollar Industry PRNewswireMay 21, 2019
U.S. To Remain Atop Global Cannabis Market Share PRNewswireMay 16, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Week In Review: How Trump's Policies Moved Stocks - June 15 2019 TalkMarkets1 day ago
CV Sciences (CVSI) Investor Presentation - Slideshow Seeking AlphaJun 07, 2019
China Redux, 13F Season And Blockchain Blockbuster (Stocks To Watch Podcast) Seeking AlphaMay 12, 2019
Stocks To Watch: China Redux, 13F Season And Blockchain Blockbuster Seeking AlphaMay 11, 2019
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2019 Results - Earnings Call Transcript Seeking AlphaMay 08, 2019
CV Sciences Q1 EPS misses; sees INDA late'19/early '20 Seeking AlphaMay 08, 2019
Five Plays On CBD: Speculating On Cannabidiol TalkMarketsApr 14, 2019
Weekly Cannabis Report: Will No-Premium Deals Become The Norm? Seeking AlphaApr 09, 2019
Weekly Cannabis Report: Was CannTrust's Miss That Bad? Seeking AlphaApr 01, 2019
The SAFE Act Could Lead To Big Changes In The North American Cannabis Industry Seeking AlphaMar 27, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q1 2019	EST	Actual	Surprise
EPS:	Expected 2019-05-08
Rev:	Expected 2019-05-08

Q2 2019	EST	Actual	Surprise
EPS:	Expected 2019-08-01
Rev:	Expected 2019-08-01

Fastest Market News Application
You'll Hear It First On Pro

Company Profile

Visit company website

Brokerage Center

Compare All Online Brokerages

Market Overview

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQBEarly-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.